超敏肌钙蛋白对维持性血液透析患者的短期预后作用

目的探讨超敏肌钙蛋白(high-sensitivity cardiac troponin T,hs-cTnT)对维持性血液透析(maintainance hemodialysis,MHD)患者的短期预后作用。方法 入组296例MHD患者,回顾性分析其临床资料,患者血液透析前采集血清检测hs-cTnT和相关心血管风险标志物。随访时间总长为13个月,记录主要终点事件(全因死亡)及发生时间;用t检验、Mann-Whitney U检验和χ2检验分析比较全因死亡与生存组风险标志物之间的差异,使用X-tile计算出hs-cTnT的最佳二分位切点,绘制Kaplan-Meier生存曲线,用Logistic回归...

Full description

Saved in:
Bibliographic Details
Published in复旦学报(医学版) Vol. 44; no. 4; pp. 447 - 452
Main Author 顾佳芸 沈波 吴炯 戴谦 曹旻璐 陈曦旻 郭玮 潘柏申
Format Journal Article
LanguageChinese
Published 复旦大学附属中山医院检验科 上海200032%复旦大学附属中山医院肾内科 上海200032 2017
Subjects
Online AccessGet full text
ISSN1672-8467
DOI10.3969/j.issn.1672-8467.2017.04.009

Cover

Abstract 目的探讨超敏肌钙蛋白(high-sensitivity cardiac troponin T,hs-cTnT)对维持性血液透析(maintainance hemodialysis,MHD)患者的短期预后作用。方法 入组296例MHD患者,回顾性分析其临床资料,患者血液透析前采集血清检测hs-cTnT和相关心血管风险标志物。随访时间总长为13个月,记录主要终点事件(全因死亡)及发生时间;用t检验、Mann-Whitney U检验和χ2检验分析比较全因死亡与生存组风险标志物之间的差异,使用X-tile计算出hs-cTnT的最佳二分位切点,绘制Kaplan-Meier生存曲线,用Logistic回归分析高危及非高危hs-cTnT之间的死亡风险比。根据hs-cTnT健康人群第99百分位点将非高危组细分为中危组和低危组来进一步评估其对MHD患者短期预后的影响。结果 MHD患者生存与全因死亡组的血清hs-cTnT水平分别为0.05(0.03~0.07)ng/mL和0.07(0.04~0.14)ng/mL(P=0.027);hs-cTnT的最佳二分位切点为0.1 ng/mL;高危组(hs-cTnT〉0.1 ng/mL)患者生存率(76.67%)显著低于非高危组(hs-cTnT≤0.1 ng/mL)患者生存率(96.62%)(P〈0.05);高危组患者死亡风险较非高危组患者高7.288倍(P〈0.001);在非高危人群组中,中危组(hs-cTnT〉0.014 ng/mL)患者生存率低于低危组(hs-cTnT≤0.014 ng/mL)患者生存率,低危组在随访期间无死亡事件发生。结论 hs-cTnT是MHD患者死亡的独立危险因素,并可作为MHD患者短期的死亡风险分级和预后评估的有力指标。
AbstractList R459.5%R446; 目的 探讨超敏肌钙蛋白(high-sensitivity cardiac troponin T,hs-cTnT)对维持性血液透析(maintainance hemodialysis,MHD)患者的短期预后作用.方法 入组296例MHD患者,回顾性分析其临床资料,患者血液透析前采集血清检测hs-cTnT和相关心血管风险标志物.随访时间总长为13个月,记录主要终点事件(全因死亡)及发生时间;用t检验、Mann-Whitney U检验和x2检验分析比较全因死亡与生存组风险标志物之间的差异,使用X-tile计算出hscTnT的最佳二分位切点,绘制Kaplan-Meier生存曲线,用Logistic回归分析高危及非高危hs-cTnT之间的死亡风险比.根据hs-cTnT健康人群第99百分位点将非高危组细分为中危组和低危组来进一步评估其对MHD患者短期预后的影响.结果 MHD患者生存与全因死亡组的血清hs cTnT水平分别为0.05 (0.03~0.07)ng/mL和0.07(0.04~0.14)ng/mL (P=0.027);hs-cTnT的最佳二分位切点为0.1 ng/mL;高危组(hs-cTnT>0.1 ng/mL)患者生存率(76.67%)显著低于非高危组(hs-cTnT≤0.1 ng/mL)患者生存率(96.62%)(P<0.05);高危组患者死亡风险较非高危组患者高7.288倍(P<0.001);在非高危人群组中,中危组(hs-cTnT>0.014 ng/mL)患者生存率低于低危组(hs-cTnT≤0.014 ng/mL)患者生存率,低危组在随访期间无死亡事件发生.结论 hs-cTnT是MHD患者死亡的独立危险因素,并可作为MHD患者短期的死亡风险分级和预后评估的有力指标.
目的探讨超敏肌钙蛋白(high-sensitivity cardiac troponin T,hs-cTnT)对维持性血液透析(maintainance hemodialysis,MHD)患者的短期预后作用。方法 入组296例MHD患者,回顾性分析其临床资料,患者血液透析前采集血清检测hs-cTnT和相关心血管风险标志物。随访时间总长为13个月,记录主要终点事件(全因死亡)及发生时间;用t检验、Mann-Whitney U检验和χ2检验分析比较全因死亡与生存组风险标志物之间的差异,使用X-tile计算出hs-cTnT的最佳二分位切点,绘制Kaplan-Meier生存曲线,用Logistic回归分析高危及非高危hs-cTnT之间的死亡风险比。根据hs-cTnT健康人群第99百分位点将非高危组细分为中危组和低危组来进一步评估其对MHD患者短期预后的影响。结果 MHD患者生存与全因死亡组的血清hs-cTnT水平分别为0.05(0.03~0.07)ng/mL和0.07(0.04~0.14)ng/mL(P=0.027);hs-cTnT的最佳二分位切点为0.1 ng/mL;高危组(hs-cTnT〉0.1 ng/mL)患者生存率(76.67%)显著低于非高危组(hs-cTnT≤0.1 ng/mL)患者生存率(96.62%)(P〈0.05);高危组患者死亡风险较非高危组患者高7.288倍(P〈0.001);在非高危人群组中,中危组(hs-cTnT〉0.014 ng/mL)患者生存率低于低危组(hs-cTnT≤0.014 ng/mL)患者生存率,低危组在随访期间无死亡事件发生。结论 hs-cTnT是MHD患者死亡的独立危险因素,并可作为MHD患者短期的死亡风险分级和预后评估的有力指标。
Abstract_FL Objective To evaluate the short-term prediction of high-sensitivity cardiac troponin T (hs-cTnT) and other cardiovascular risk biomarkers in patients undergoing maintenance hemodialysis (MHD).Methods We conducted a cohort survey in 296 consecutive MHD patients whose clinical data were retrospectively analyzed.Before MHD,hs-cTnT and other relative cardiovascular biomarkers were detected.The end point (all-cause death) and time of occurring were recorded in the next 13 months.The differences between survival and all-cause death were analyzed by t-test,Mann-Whitney test and x2 test.The best two percentile cutoff point was calculated by X-tile and the survival rate was calculated by Kaplan-Meier Logistic regression analysis was applied to analyze the odd ratio between high risk and non-high risk hs-cTnT group.Non-high risk group was divided into intermediate risk and low risk group based on the 99th percentile of hs-cTnT in healthy population,to further evaluate its short-term prediction value for MHD patients.The short-term significance of hs-cTnT was proved to be independently associated with all-cause death by Logistic regression analysis.Results The mean value of serum hs-cTnT in survival group was 0.05 (0.03~0.07) ng/mL,while in the death group it was 0.07 (0.04~0.14) ng/mL,which had statistical significance (P =0.027).The best two percentile cutoff of hs-cTnT in MHD patients was 0.1 ng/mL.The survival rate in high risk group (hs-cTnT>0.1 ng/mL) is lower than it in non-high risk group (hs-cTnT≤0.1 ng/mL) (76.67% vs.96.62%,P <0.05).The odd ratios for high risk group and non-high risk group was 7.288 (P< 0.001).Moreover,further grouping the non-high risk group by hs-cTnT =0.014 ng/mL,intermediate risk group (hs-cTnT>0.014 ng/mL) group has lower survival rate than low risk group (hs-cTnT≤0.014ng/mL),while there wasn't any death case occurred in the low risk group.Conclusions Hs-cTnT is an independent risk factor to all-cause death.Thus hs-cTnT can be a strong indicator of short-term prediction and prognostic evaluation.
Author 顾佳芸 沈波 吴炯 戴谦 曹旻璐 陈曦旻 郭玮 潘柏申
AuthorAffiliation 复旦大学附属中山医院检验科,上海200032 复旦大学附属中山医院肾内科,上海200032
AuthorAffiliation_xml – name: 复旦大学附属中山医院检验科 上海200032%复旦大学附属中山医院肾内科 上海200032
Author_FL WU Jiong
GU Jia-yun
GUO Wei
CHEN Xi-min
DAI Qian
SHEN Bo
PAN Bai-shen
CAO Min-lu
Author_FL_xml – sequence: 1
  fullname: GU Jia-yun
– sequence: 2
  fullname: SHEN Bo
– sequence: 3
  fullname: WU Jiong
– sequence: 4
  fullname: DAI Qian
– sequence: 5
  fullname: CAO Min-lu
– sequence: 6
  fullname: CHEN Xi-min
– sequence: 7
  fullname: GUO Wei
– sequence: 8
  fullname: PAN Bai-shen
Author_xml – sequence: 1
  fullname: 顾佳芸 沈波 吴炯 戴谦 曹旻璐 陈曦旻 郭玮 潘柏申
BookMark eNo9kM1LAkEAxedgkJn_RHTpsNvszOx8HEPsA4Qu3mVmP3St1nKJ9GaipyQl6mBJUh3qEkGEEOF_k7vrf9GG0enB48d7vLcCUn7NdwBYN6COBRWbVd0LAl83KEMaJ5TpCBpMh0SHUKRA-t9fBtkg8BSECGLBMEqDfDzphjf9uN2bXw3ju4toOJ29fUZfH2HvPGw9xw-tcPI-b_XD-0HYfopb3ei2E41fw9F4_tiZDS6_p6Po-mUVLLnyMHCyf5oBxe18MberFfZ39nJbBc2ihtAQJQ5kLuGKcGFTWyLFGIcO5qYpGWXQhVRxaUrIseEQCyJlUSKUSxyiLGnjDNhYxJ5J35V-uVStndb9pLAUVJoHdqOhfndDkqxO2LUFa1VqfvnES-jjunck681S8oZAwsQc_wCw9HUV
ClassificationCodes R459.5%R446
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3969/j.issn.1672-8467.2017.04.009
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
维普中文期刊数据库
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate The short-term prediction of high-sensitivity cardiac troponin T in patients undergoing maintenance hemodialysis
DocumentTitle_FL The short-term prediction of high-sensitivity cardiac troponin T in patients undergoing maintenance hemodialysis
EndPage 452
ExternalDocumentID shykdxxb201704009
672929538
GrantInformation_xml – fundername: 国家自然科学基金面上项目; 上海市卫生计生系统重要薄弱学科建设项目(2015ZB0201)This work was supported by the General Program of National Natural Science Foundation of China; the Key Developing Disciplines of Shanghai Municipal Commission of Health and Family Planning
  funderid: (81572064); (81572064); (2015ZB0201)
GroupedDBID -05
2B.
2C~
2RA
5XA
5XF
92F
92I
92L
ABDBF
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CIEJG
CQIGP
DIK
TCJ
TGQ
U1G
U5O
W91
~WA
4A8
93N
ACUHS
PSX
ID FETCH-LOGICAL-c619-264e07f48b489d6da2b7780e3855a7670f06b8a5a0831e4c02bc649bf4e4bcad3
ISSN 1672-8467
IngestDate Thu May 29 04:01:16 EDT 2025
Wed Feb 14 09:57:59 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords risk stratification
危险分级
maintenance hemodialysis
预后评估
超敏肌钙蛋白
prognostic evaluation
high-sensitivity cardiac troponin T
维持性血液透析
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c619-264e07f48b489d6da2b7780e3855a7670f06b8a5a0831e4c02bc649bf4e4bcad3
Notes GU Jia-yun1, SHEN Bo2 , WU Jiong1, DAI Qian1 , CAO Min-lu1 , CHEN Xi-min1, GUO Wei1, PAN Bai-shen1(1 Department of Clinical Laboratory Medicine, 2 Department of Nephrology, Zhongshan Hospital Fudan University, Shanghai 200032, China)
high-sensitivity cardiac troponin T; maintenance hemodialysis; risk stratification;prognostic evaluation
Objective To evaluate the short-term prediction of high-sensitivity cardiac troponin T (hs-cTnT) and other cardiovascular risk biomarkers in patients undergoing maintenance hemodialysis (MHD). Methods We conducted a cohort survey in 296 consecutive MHD patients whose clinical data were retrospectively analyzed. Before MHD, hs-cTnT and other relative cardiovascular biomarkers were detected. The end point (all-cause death) and time of occurring were recorded in the next 13 months. The differences between survival and all-cause death were analyzed by t-test, Mann-Whitney test and χ2 test. The best two percentile cutoff point was calculated by X-tile and the survival rate was calcul
PageCount 6
ParticipantIDs wanfang_journals_shykdxxb201704009
chongqing_primary_672929538
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 复旦学报(医学版)
PublicationTitleAlternate Fudan University Journal of Medical Sciences
PublicationTitle_FL Fudan University Journal of Medical Sciences
PublicationYear 2017
Publisher 复旦大学附属中山医院检验科 上海200032%复旦大学附属中山医院肾内科 上海200032
Publisher_xml – name: 复旦大学附属中山医院检验科 上海200032%复旦大学附属中山医院肾内科 上海200032
SSID ssib002039732
ssib036437206
ssib051371206
ssj0001844257
ssib002423895
ssib038076145
ssib002805881
ssib006704044
ssib001104042
ssib005319430
Score 2.1048734
Snippet 目的探讨超敏肌钙蛋白(high-sensitivity cardiac troponin T,hs-cTnT)对维持性血液透析(maintainance hemodialysis,MHD)患者的短期预后作用。方法 入组296例MHD患者,回...
R459.5%R446; 目的 探讨超敏肌钙蛋白(high-sensitivity cardiac troponin T,hs-cTnT)对维持性血液透析(maintainance hemodialysis,MHD)患者的短期预后作用.方法 入组296...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 447
SubjectTerms 危险分级
维持性血液透析
超敏肌钙蛋白
预后评估
Title 超敏肌钙蛋白对维持性血液透析患者的短期预后作用
URI http://lib.cqvip.com/qk/91097A/201704/672929538.html
https://d.wanfangdata.com.cn/periodical/shykdxxb201704009
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  issn: 1672-8467
  databaseCode: ABDBF
  dateStart: 20160701
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  omitProxy: true
  ssIdentifier: ssj0001844257
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  issn: 1672-8467
  databaseCode: DIK
  dateStart: 20080101
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: http://www.freemedicaljournals.com
  omitProxy: true
  ssIdentifier: ssj0001844257
  providerName: Flying Publisher
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFB_6AeJFFBVrVYp0TmVrNplkZo4zu1mKoKcKvS1JNmlB2FZbofa0lvZksUX0UC0W9aAXEUQKIv1v7O72v_C9mTQbRYp6CZM3b-a9-U2S9zIfbwiZdJzYSZhbraTM5xXGvaQStdykkka-qKaRzHxzFsGdu8HMPXZ7zp8bGv5ld8lKPJ2s_XFfyf_0KtCgX3GX7D_0bFEpECAN_QtX6GG4_lUf01BQHVDh0zCg0qeigRThUlGjoaTSpVIiRWoqNA053uo6DX2qGlRLpGhNNcPiUERUTcKhimMpVcU0UECEdrFCuEURICuk0mSBLOUZoY5RA0QoKphJNKiqG-YapqG4ck2Wj2VFSEOGykAuMjOqRNlRNkqCn2tr4FQFhlI3CZCrqAJx0IoaSoQs0B_aMuDhVIDCxUJdI79K9YlYbbVWVIsp00bQTZiEB3pO5Vpq0xJsZMNwAQuS4AogBYYE2CKSRkltQQbYnSnTATKvFJis3obJ5AnPwMMRCRVaHQANy94wOBtYtFcemLE7UHMrEnAwM8yeM3JiZmyYy_x1YiWbwWzI0dz9YDag7--WzZOBNJYNBUwXAnBtIjexeh05sOjFOktgA_cXbNowGXVxwGqEjCpd142Bxwy_4w4rTaw7HsZvKntw4NKWPGrh-OUDCPATXg7gH3Csr_jEe2ZeeDCRj8cbBKWJbL_q8epJvhkWFYzZ-LxFG8-QyRyAW6c1H4OjLCy25x-Ay2d24LWzqD1fchZnz5Nz-V_ehLKv7AUytLZwkYT9g83uy-3--tbx893-66e93cOjz9963792t550Ox_6bzvdgy_Hne3um53u-vt-Z7P3aqO3_6m7t3_8buNo59mPw73ei4-XyGwjnK3NVPJTTCoJAI4rSFOHZ0zETMhW0IrcmHPhpJ7w_YgDXJkTxCLyIzzyL2WJ48ZJwGScsZTFSdTyLpOR9mI7vUImMrhrpTJzY1-C7wm_dlxm3BVBHCRpK-ZjZLxAoLlkg9U0i0dgjNzMMWnmn7Dl5vLC4_ut1dUYYURrLq-eWsU4OYucdgTyGhlZefgovQ4--Up8I3-ufgKCb6cX
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%B6%85%E6%95%8F%E8%82%8C%E9%92%99%E8%9B%8B%E7%99%BD%E5%AF%B9%E7%BB%B4%E6%8C%81%E6%80%A7%E8%A1%80%E6%B6%B2%E9%80%8F%E6%9E%90%E6%82%A3%E8%80%85%E7%9A%84%E7%9F%AD%E6%9C%9F%E9%A2%84%E5%90%8E%E4%BD%9C%E7%94%A8&rft.jtitle=%E5%A4%8D%E6%97%A6%E5%AD%A6%E6%8A%A5%EF%BC%9A%E5%8C%BB%E5%AD%A6%E7%89%88&rft.au=%E9%A1%BE%E4%BD%B3%E8%8A%B8+%E6%B2%88%E6%B3%A2+%E5%90%B4%E7%82%AF+%E6%88%B4%E8%B0%A6+%E6%9B%B9%E6%97%BB%E7%92%90+%E9%99%88%E6%9B%A6%E6%97%BB+%E9%83%AD%E7%8E%AE+%E6%BD%98%E6%9F%8F%E7%94%B3&rft.date=2017&rft.issn=1672-8467&rft.volume=44&rft.issue=4&rft.spage=447&rft.epage=452&rft_id=info:doi/10.3969%2Fj.issn.1672-8467.2017.04.009&rft.externalDocID=672929538
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F91097A%2F91097A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fshykdxxb%2Fshykdxxb.jpg